1. Home
  2. ATHM vs GHRS Comparison

ATHM vs GHRS Comparison

Compare ATHM & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATHM

Autohome Inc.

N/A

Current Price

$20.77

Market Cap

2.4B

Sector

Technology

ML Signal

N/A

Logo GH Research PLC

GHRS

GH Research PLC

N/A

Current Price

$21.07

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATHM
GHRS
Founded
2008
2018
Country
China
Ireland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
ATHM
GHRS
Price
$20.77
$21.07
Analyst Decision
Hold
Strong Buy
Analyst Count
13
10
Target Price
$21.40
★ $42.89
AVG Volume (30 Days)
★ 365.4K
268.4K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
★ 8.79%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
$12.13
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.57
$12.04
52 Week High
$28.08
$31.44

Technical Indicators

Market Signals
Indicator
ATHM
GHRS
Relative Strength Index (RSI) 41.82 29.00
Support Level $20.62 $19.75
Resistance Level $22.24 $22.88
Average True Range (ATR) 0.51 1.36
MACD -0.04 -0.39
Stochastic Oscillator 32.86 14.39

Price Performance

Historical Comparison
ATHM
GHRS

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent, and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead-generation service provider in China's online auto platform media advertising market, in terms of media services and lead-generation revenue.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: